United Kingdom Archives

News and Trends 1 Sep 2016

Infographic: How Cancer Starts & How It Chooses Organs

Here’s a neat infographic from Cancer Research UK summarizing a new Cell report from UK researchers that describes how conditions build to trigger cancer. This information would help to explain the greater vulnerability of certain organs to tumors compared to others. The team, headed by Richard James Gilbertson, demonstrated that while cells may start with equal carcinogenic risk, tumor […]

September 1, 2016 - 1 minutemin - By Evelyn Warner

News and Trends 1 Sep 2016

GSK is Advancing a Revolutionary Dual HIV Therapy

Gilead has long been the leader in HIV treatments, but GlaxoSmithKline’s CEO revealed to the WSJ that the company has been investing in the field. It could give Gilead a run for its money with dolutegravir, a new integrase inhibitor so powerful it may knock the standard down from triple to dual therapy. Since the […]

September 1, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 27 Aug 2016

European BioArtists featured in Online Exhibition by Pioneering New York Platform

SciArt Center, a New York-based organisation for the collaboration of scientists and artists on all manner of endeavours, has just opened an online exhibition of bioart featuring a number of European artists. The exhibit, titled, “EmBodied,” explores the understanding of our souls through the human body. The human body is the best picture to the […]

August 27, 2016 - 4 minutesmins - By Evelyn Warner

News and Trends 26 Aug 2016

US Money Magnet get hands on UK Bispecific Antibodies for Neurodegenerative Disease

F-star’s “plug-and-play” technology can turn any existing antibody into a full-size bispecific antibody. Denali has recognized its potential use for drug delivery to the CNS and inked a deal with the UK-based company for almost €1B. Denali (US) and F-Star (UK) have struck a deal to develop F-star’s Modular Antibody Technology™ for the generation of […]

August 26, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 26 Aug 2016

UCL & Cell Medica start a TCR Collaboration towards a Cancer Cure

Bridging the divide between academia and industry, Cell Medica and UCL are teaming up on TCR engineering in the effort to find a cancer cure. Not many details were disclosed, but cancer now has a new force to reckon with. For the most part, scientists thrive on competition, and what better fuel is there than […]

August 26, 2016 - 2 minutesmins - By Evelyn Warner

In Depth 23 Aug 2016

5 Expert Tips to Success When Building a Biotech Startup

Succeeding as an entrepreneur is tough, you will have to deal with failure and learn from it along the way. Many new biotech startups face similar problems during their early steps, here are some expert tips on how to avoid them. Last week, I had the opportunity to meet Mark Hammond and Dominic Falcao, who […]

August 23, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 22 Aug 2016

This new vaccine could tackle both Zika and Dengue at once

These potentially fatal diseases have reached pandemic proportions and are starting to threaten the Western world. Excivion (UK) and Xenetic (US) have announced a partnership to develop a combined vaccine for Dengue and Zika Viruses using new vaccine delivery technology. Following on Sanofi’s initiatives to combat the spread of Zika and Dengue viruses, a transatlantic partnership between […]

August 22, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 18 Aug 2016

Invidior approaches FDA Approval of Opioid Addiction Treatment

Invidior has revamped buprenorphine with a sustained release formulation known as RBP-6000 that shows promising results in Phase III clinical trials for the treatment of opioid addiction. The latest addiction treatment from Invidior, RBP-6000, has made considerable progress through Phase III clinical trials. At the core of RBP-6000 is the old drug, buprenorphine, but Invidior has […]

August 18, 2016 - 3 minutesmins - By Evelyn Warner

synthetic biology bioelectronics igem living lightbulb

News and Trends 17 Aug 2016

Illuminating Synthetic Biology: Undergraduate team develops a bioelectric lightbulb

A group of undergraduate researchers at Newcastle University has created a lightbulb from genetically engineered E. coli. In the pipeline are also a hybridised batteries, a capacitor, and a resistor, and the forthcoming circuit will serve as the team’s entry into 2016’s iGEM competition. We’ve heard of fungi furniture, but synthetic biology is extending tendrils into another area of interior design: […]

August 17, 2016 - 2 minutesmins - By Evelyn Warner

astrazeneca moderna mrna biotech investing

News and Trends 12 Aug 2016

mRNA Money-magnet increases its Pile of Cash to over €1.3Bn

Moderna is taking Biotech investing to new heights, as it has now increased total fundraising&partnership cash to an unbelievable €1.34Bn ($1.5Bn). It can thank AstraZeneca, which is now adding €126M more to its investment. Amid dropping revenues and pipeline cuts, AstraZeneca remains steadily focused on innovation and Biotech. After all, this was the strategy CEO Pascal […]

August 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

hereditary edema KVD818 kalvista protease inhibitor

News and Trends 11 Aug 2016

New First-in-Human trial for rare Hereditary Angioedema begins in the UK

A new drug by KalVista is starting a Phase I trial. The drug could become a preventive treatment for people suffering for hereditary angioedema, a rare genetic condition that can be life-threatening. Based in the Tetricus Science Park (UK), KalVista targets proteases that are involved in diseases. It develops small molecule inhibitors for plasma kallikrein, an enzyme involved […]

August 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

astrazeneca phase III failure nsclc selumetinib

News and Trends 11 Aug 2016

This new Phase III Failure adds up to AstraZeneca’s Troubles

AstraZeneca’s oncology pipeline takes a hit, as one of its Phase III trials failed to meet its primary endpoint. The program targeted advanced non-small lung cancer. It looks like it’s up to immunotherapies now. Now struggling for a while, AstraZeneca has been refocusing on cancer and investing big in new candidates. The strategy hasn’t yet […]

August 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Infographic: How Cancer Starts & How It Chooses Organs

GSK is Advancing a Revolutionary Dual HIV Therapy

European BioArtists featured in Online Exhibition by Pioneering New York Platform

US Money Magnet get hands on UK Bispecific Antibodies for Neurodegenerative Disease

UCL & Cell Medica start a TCR Collaboration towards a Cancer Cure

5 Expert Tips to Success When Building a Biotech Startup

This new vaccine could tackle both Zika and Dengue at once

Invidior approaches FDA Approval of Opioid Addiction Treatment

Illuminating Synthetic Biology: Undergraduate team develops a bioelectric lightbulb

mRNA Money-magnet increases its Pile of Cash to over €1.3Bn

New First-in-Human trial for rare Hereditary Angioedema begins in the UK

This new Phase III Failure adds up to AstraZeneca’s Troubles

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!